Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.
Read More…
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
Phone31-20-521-4777
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$836.19 million
Profitability
Miscellaneous
Employees2,894
Next Earnings Date11/6/2019 (Estimated)
OptionableOptionable
Wright Medical Group (NASDAQ:WMGI) Frequently Asked Questions
What is Wright Medical Group's stock symbol?
Wright Medical Group trades on the NASDAQ under the ticker symbol "WMGI."
How often does Wright Medical Group pay dividends? What is the dividend yield for Wright Medical Group?
Wright Medical Group declared a dividend on Tuesday, December 11th. Stockholders of record on Wednesday, December 5th will be paid a dividend of $1.50 per share on Monday, December 10th. The ex-dividend date of this dividend is Wednesday, December 12th. View Wright Medical Group's Dividend History.
How were Wright Medical Group's earnings last quarter?
Wright Medical Group NV (NASDAQ:WMGI) announced its quarterly earnings data on Wednesday, August, 7th. The medical device company reported $0.02 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.01 by $0.01. The medical device company had revenue of $229.73 million for the quarter, compared to the consensus estimate of $233.04 million. Wright Medical Group had a positive return on equity of 1.38% and a negative net margin of 14.65%. The firm's revenue for the quarter was up 11.8% on a year-over-year basis. During the same period in the prior year, the business posted ($0.03) earnings per share. View Wright Medical Group's Earnings History.
When is Wright Medical Group's next earnings date?
What guidance has Wright Medical Group issued on next quarter's earnings?
Wright Medical Group issued an update on its FY19 earnings guidance on Wednesday, August, 7th. The company provided earnings per share guidance of $0.15-0.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.22. The company issued revenue guidance of ~$925-930 million, compared to the consensus revenue estimate of $961.36 million.
What price target have analysts set for WMGI?
12 equities research analysts have issued 1-year target prices for Wright Medical Group's stock. Their forecasts range from $23.00 to $40.00. On average, they anticipate Wright Medical Group's stock price to reach $30.50 in the next year. This suggests a possible upside of 46.4% from the stock's current price. View Analyst Price Targets for Wright Medical Group.
What is the consensus analysts' recommendation for Wright Medical Group?
12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Wright Medical Group in the last year. There are currently 4 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Wright Medical Group.
What are Wall Street analysts saying about Wright Medical Group stock?
Here are some recent quotes from research analysts about Wright Medical Group stock:
- 1. Needham & Company LLC analysts commented, "WMGI’s 4Q18 revenue was consistent with its preannouncement while EBITDA and EPS beat consensus. For 2019, management provided revenue, EBITDA, and EPS guidance that all bracketed consensus. Organic revenue growth slowed to 10.1% (adjusted for selling days) from 14.4% in 3Q18 as strong US Lower Extremities growth was offset by slower US Upper Extremities growth (faced its toughest comp of the year). Given the improving Lower Extremities growth, Augment Injectable launch, and Cartiva acquisition, we have increased confidence that WMGI can exceed consensus in 2019 despite some likely moderation in its US Upper Extremities growth and we reiterate our Buy rating." (2/27/2019)
- 2. Cantor Fitzgerald analysts commented, "We reiterate our Overweight rating and a 12-month price target of $35 on shares of WMGI. We think WMGI is positioned to outperform expectations in 2018 with multiple drivers across each of its three primary segments (lower extremities, upper extremities, and biologics) to accelerate growth. We see WMGI’s valuation as attractive, as we expect innovative products to help WMGI to capitalize on the evolving market trends. Valuation Summary We base our $35 price target on a ~5.5x EV/Sales multiple on our 2019 sales estimate." (12/10/2018)
Has Wright Medical Group been receiving favorable news coverage?
Media stories about WMGI stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Wright Medical Group earned a media sentiment score of -1.3 on InfoTrie's scale. They also gave media coverage about the medical device company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Wright Medical Group.
Who are some of Wright Medical Group's key competitors?
Some companies that are related to Wright Medical Group include DEMANT A S/ADR (WILYY), MSA Safety (MSA), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN), Invacare (IVC), RTI Surgical (RTIX), ConforMIS (CFMS), Lakeland Industries (LAKE), Rewalk Robotics (RWLK), Histogenics (HSGX), Precision Therapeutics (POAI), COLLPLANT HOLDI/S (CLGN) and Bionik Laboratories (BNKL).
What other stocks do shareholders of Wright Medical Group own?
Who are Wright Medical Group's key executives?
Wright Medical Group's management team includes the folowing people:
- Mr. Robert J. Palmisano, Pres, CEO & Exec. Director (Age 74)
- Mr. Lance A. Berry, Exec. VP, CFO & COO (Age 47)
- Mr. Andrew C. Morton, Sr. VP & Chief HR Officer (Age 53)
- Mr. Kevin D. Cordell, Exec. VP & Chief Global Commercial Officer (Age 53)
- Mr. Peter S. Cooke, Pres of emerging markets, Australia & Japan (Age 54)
Who are Wright Medical Group's major shareholders?
Wright Medical Group's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.99%), BlackRock Inc. (8.68%), BlackRock Inc. (8.68%), Price T Rowe Associates Inc. MD (7.43%), Scepter Holdings Inc. (3.95%) and Orbimed Advisors LLC (3.31%). Company insiders that own Wright Medical Group stock include Andrew C Morton, Barry J Regan, David D Stevens, Elizabeth H Weatherman, Gregory Morrison, James Lightman, Jennifer S Walker, John L Miclot, Jonathan Wesley Porter, Julie Andrews, Julie D Dewey, Kevin C Oboyle, Kevin D Cordell, Lance A Berry, Patrick Fisher, Peter Cooke, Richard F Wallman, Robert J Palmisano, Robert P Burrows III and Tim Lanier. View Institutional Ownership Trends for Wright Medical Group.
Which institutional investors are selling Wright Medical Group stock?
WMGI stock was sold by a variety of institutional investors in the last quarter, including Scepter Holdings Inc., Point72 Asset Management L.P., Renaissance Technologies LLC, Orbimed Advisors LLC, Keeley Teton Advisors LLC, Columbus Circle Investors, Price T Rowe Associates Inc. MD and AXA. Company insiders that have sold Wright Medical Group company stock in the last year include Andrew C Morton, David D Stevens, Elizabeth H Weatherman, John L Miclot, Jonathan Wesley Porter, Julie Andrews, Julie D Dewey, Kevin C Oboyle, Kevin D Cordell, Lance A Berry, Patrick Fisher, Peter Cooke and Tim Lanier. View Insider Buying and Selling for Wright Medical Group.
Which institutional investors are buying Wright Medical Group stock?
WMGI stock was acquired by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, BlackRock Inc., BlackRock Inc., Eagle Asset Management Inc., Carillon Tower Advisers Inc., Canada Pension Plan Investment Board, Landscape Capital Management L.L.C. and Marshall Wace LLP. Company insiders that have bought Wright Medical Group stock in the last two years include Barry J Regan, Elizabeth H Weatherman, Richard F Wallman and Robert J Palmisano. View Insider Buying and Selling for Wright Medical Group.
How do I buy shares of Wright Medical Group?
Shares of WMGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Wright Medical Group's stock price today?
One share of WMGI stock can currently be purchased for approximately $20.83.
How big of a company is Wright Medical Group?
What is Wright Medical Group's official website?
How can I contact Wright Medical Group?
Wright Medical Group's mailing address is PRINS BERNHARDPLEIN 200, AMSTERDAM P7, 1097 JB. The medical device company can be reached via phone at 31-20-521-4777 or via email at [email protected]
MarketBeat Community Rating for Wright Medical Group (NASDAQ WMGI)
MarketBeat's community ratings are surveys of what our community members think about Wright Medical Group and other stocks. Vote "Outperform" if you believe WMGI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WMGI will underperform the S&P 500 over the long term. You may vote once every thirty days.
